Alphatec Holdings, Inc. Announces Webcast and Conference Call to Review Q1 2008 Results

CARLSBAD, Calif., April 10, 2008 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc.
(Nasdaq:ATEC), a leading medical device company focused on the design,
development, manufacturing and marketing of products for the surgical treatment
of spine disorders, will conduct a webcast and conference call with analysts and
investors following the release of its first quarter 2008 results on Thursday,
April 24, 2008 at 1:30 p.m. PT / 4:30 p.m. ET.

After the close of the market on Thursday, April 24, 2008 and prior to the
conference call, Alphatec will distribute a copy of the first quarter 2008
results press release. To listen to the webcast, or to view the press release,
please visit the investor relations section of the Alphatec website at
www.alphatecspine.com. The dial-in numbers are (877) 681-3375 for domestic
callers and (719) 325-4915 for international. A live webcast of the conference
call will be available online from the investor relations section of the
Company's corporate Web site at www.alphatecspine.com. The webcast will be
recorded and will remain available on the investor relations section of
Alphatec's website, www.alphatecspine.com, for one year.

About Alphatec

Alphatec Holdings, Inc. (Nasdaq:ATEC) designs, develops, manufactures and
markets products for the surgical treatment of spine disorders. Alphatec's broad
product portfolio and pipeline includes a variety of spinal implant products and
systems focused on solutions addressing the cervical, thoracolumbar,
intervertebral, minimally invasive, motion preservation, vertebral compression
fractures and allograft markets. Alphatec's "surgeons' culture" emphasizes
collaboration with spinal surgeons to conceptualize, design and co-develop a
broad range of products. State-of-the-art in-house manufacturing capabilities
provide a unique competitive advantage, enabling Alphatec to rapidly deliver
customized solutions to meet surgeons' and patients' critical needs. Alphatec
has 23 issued U.S. patents, six issued foreign patents and 30 pending patent
applications, including 10 pending U.S. applications, six pending international
applications and 15 pending foreign national applications. Alphatec's principal
product offerings are primarily focused on the global spine implant and
biologics market, which is estimated to be more than $7.0 billion in 2007. In
addition to its U.S. operations, Alphatec also markets a range of spine and
orthopedic products in Asia through its subsidiary, Alphatec Pacific, Inc. For
more information, please visit www.alphatecspine.com.

The Alphatec Holdings, Inc. logo is available at
http://www.primenewswire.com/newsroom/prs/?pkgid=3520

-0-
CONTACT: Alphatec Holdings, Inc.
Gordon C. Bigler, Vice President of Finance, Investor
Relations & Corp. Communications
760.494.6667
gbigler@alphatecspine.com